Mannkind (MNKD) Net Margin Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3,082.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,120.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -653.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,849.00 |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -3,522.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,522.00 |
| Dec 31, 2025 | -2,832.00 |
| Sep 30, 2025 | -676.00 |
| Jun 30, 2025 | 366.00 |
| Mar 31, 2025 | 75.00 |
| Dec 31, 2024 | 725.00 |
| Sep 30, 2024 | 950.00 |
| Jun 30, 2024 | 805.00 |
| Mar 31, 2024 | 4,015.00 |
| Dec 31, 2023 | 5,218.00 |
| Sep 30, 2023 | 5,095.00 |
| Jun 30, 2023 | 966,350.00 |
| Mar 31, 2023 | 19,268.00 |
| Dec 31, 2022 | 17,445.00 |
| Sep 30, 2022 | -2,404.00 |
| Jun 30, 2022 | -952,174.00 |
| Mar 31, 2022 | -14,272.00 |
| Dec 31, 2021 | -8,102.00 |
| Sep 30, 2021 | 5,339.00 |
| Jun 30, 2021 | 497,341.00 |
| Mar 31, 2021 | -1,666.00 |
| Dec 31, 2020 | -5,939.00 |
| Sep 30, 2020 | 140,812.00 |
| Jun 30, 2020 | 106,750.00 |
| Mar 31, 2020 | 2,788.00 |
| Dec 31, 2019 | -3,876.00 |
| Sep 30, 2019 | -94,064.00 |
| Jun 30, 2019 | -561,104.00 |
| Mar 31, 2019 | 79,161.00 |
| Dec 31, 2018 | -183,082.00 |
| Sep 30, 2018 | 106,890.00 |
| Jun 30, 2018 | 105,134.00 |
| Mar 31, 2018 | -33,441.00 |
| Dec 31, 2017 | 135,063.00 |
| Sep 30, 2017 | -168,762.00 |